Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis

References

• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• Van CutsemESagaertXTopalBHaustermansKPrenenHGastric cancerLancet Epub201655
   Google Scholar
• AmedeiABenagianoMdella BellaCNiccolaiED’EliosMMNovel immunotherapeutic strategies of gastric cancer treatmentJ Biomed Biotechnol2011201143734822253528
   PubMedGoogle Scholar
• SawadaTYashiroMSentaniKNew molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committeeGastric Cancer201518111912824488015
   PubMedGoogle Scholar
• XingXTangYBYuanGThe prognostic value of E-cadherin in gastric cancer: a meta-analysisInt J Cancer2013132112589259623169395
   PubMed Web of Science ®Google Scholar
• WuPWuDZhaoLPrognostic role of STAT3 in solid tumors: a systematic review and meta-analysisOncotarget2016715198631988326959884
   PubMedGoogle Scholar
• YimingLYunshanGBoMCD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysisOncotarget2015639420194202726503471
   PubMedGoogle Scholar
• YildirimMKayaVDemirpenceOGunduzSBozcukHPrognostic significance of p53 in gastric cancer: a meta-analysisAsian Pac J Cancer Prev201516132733225640374
   PubMedGoogle Scholar
• Soleyman-JahiSNedjatSAbdiradAHoorshadNHeidariRZendehdelKPrognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysisPLoS One2014104e012231625919283
   PubMedGoogle Scholar
• PetrelliFCabidduMCoinuAPrognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studiesActa Oncol201554796197025984930
   PubMed Web of Science ®Google Scholar
• MiyachiKFritzlerMJTanEMAutoantibody to a nuclear antigen in proliferating cellsJ Immunol1978121622282234102692
   PubMedGoogle Scholar
• MathewsMBBernsteinRMFranzaBRJrGarrelsJIIdentity of the proliferating cell nuclear antigen and cyclinNature198430959663743766145097
   PubMed Web of Science ®Google Scholar
• BravoRCelisJEA search for differential polypeptide synthesis throughout the cell cycle of HeLa cellsJ Cell Biol19808437958026892640
   PubMedGoogle Scholar
• BravoRFeySJBellatinJLarsenPMArevaloJCelisJEIdentification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferationExp Cell Res198113623113197308310
   PubMedGoogle Scholar
• SrinivasanMJewellSDQuantitative estimation of PCNA, c-myc, EGFR and TGF-alpha in oral submucous fibrosis – an immunohistochemical studyOral Oncol200137546146711377235
   PubMedGoogle Scholar
• MoldovanGLPfanderBJentschSPCNA, the maestro of the replication forkCell2007129466567917512402
   PubMed Web of Science ®Google Scholar
• StoimenovIHelledayTPCNA on the crossroad of cancerBiochem Soc Trans200937Pt 360561319442257
   PubMedGoogle Scholar
• WangLFChaiCYKuoWRTaiCFLeeKWHoKYCorrelation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinomaAm J Otolaryngol200627210110516500472
   PubMed Web of Science ®Google Scholar
• LiuCLiuJWangXPrognostic impact of nm23-H1 and PCNA expression in pathologic stage I non-small cell lung cancerJ Surg Oncol2011104218118621495034
   PubMedGoogle Scholar
• BantisAGiannopoulosAGonidiMExpression of p120, Ki-67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic valueCytopathology2004151253114748788
   PubMedGoogle Scholar
• LiNDengWMaJPrognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancerMed Oncol201532143325491144
   PubMed Web of Science ®Google Scholar
• LvQZhangJYiYProliferating cell nuclear antigen has an association with prognosis and risks factors of cancer patients: a systematic reviewMol Neurobiol20165396209621726558632
   PubMed Web of Science ®Google Scholar
• LiuMLiJSTianDPHuangBRosqvistSSuMMCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancerHistol Histopathol201328448149223329420
   PubMed Web of Science ®Google Scholar
• YangCWenYLiHOverexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancerOncol Rep201227113514221947329
   PubMed Web of Science ®Google Scholar
• KonnoSTakebayashiYAibaMAkiyamaSOgawaKClinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinomaCancer Lett2001166110311111295293
   PubMedGoogle Scholar
• CzyzewskaJGuzinska-UstymowiczKPryczyniczAKemonaABandurskiRImmunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancerFolia Histochem Cytobiol200947228929619995716
   PubMed Web of Science ®Google Scholar
• LeeKELeeHJKimYHPrognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancerJpn J Clin Oncol200333417317912810831
   PubMed Web of Science ®Google Scholar
• StangACritical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol201025960360520652370
   PubMed Web of Science ®Google Scholar
• ParmarMKTorriVStewartLExtracting summary statistics to perform meta-analyses of the published literature for survival endpointsStat Med19981724281528349921604
   PubMed Web of Science ®Google Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials200781617555582
   PubMed Web of Science ®Google Scholar
• PetersJLSuttonAJJonesDRAbramsKRRushtonLComparison of two methods to detect publication bias in meta-analysisJAMA2006295667668016467236
   PubMed Web of Science ®Google Scholar
• PotecaTPotecaASajinMComanescuMBiological prognostic parameters in gastric carcinomasChirurgia (Bucur)2014109334735424956340
   PubMedGoogle Scholar
• KuangRGWuHXHaoGXWangJWZhouCJExpression and significance of IGF-2, PCNA, MMP-7, and alpha-actin in gastric carcinoma with Lauren classificationTurk J Gastroenterol20132429910823934455
   PubMedGoogle Scholar
• YeYWDongRZZhouYPrognostic analysis of familial gastric cancer in Chinese populationJ Surg Oncol20111041768221400534
   PubMedGoogle Scholar
• KanajiSSaitoHTsujitaniSExpression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinomaOncology200670212613316645325
   PubMed Web of Science ®Google Scholar
• WuKZhaoLLiYShanYJWuLJEffects of vitamin E succinate on the expression of Fas and PCNA proteins in human gastric carcinoma cells and its clinical significanceWorld J Gastroenterol200410794594915052671
   PubMedGoogle Scholar
• NodaHMaeharaYIrieKKakejiYYonemuraTSugimachiKIncreased proliferative activity caused by loss of p21(WAF1/CIP1) expression and its clinical significance in patients with early-stage gastric carcinomaCancer20029472107211211932915
   PubMedGoogle Scholar
• ElpekGOGelenTAksoyNHKarpuzogluTKelesNMicrovessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinomaPathol Oncol Res200061596410749590
   PubMedGoogle Scholar
• DanesiDTSpanoMFabianoAFlow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patientsCytometry2000421273410679740
   PubMedGoogle Scholar
• KinugasaSAbeSTachibanaMOverexpression of transforming growth factor-beta1 in scirrhous carcinoma of the stomach correlates with decreased survivalOncology19985565825879778627
   PubMedGoogle Scholar
• MaedaKChungYSTakatsukaSTumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinomaBr J Cancer19957223193237543771
   PubMed Web of Science ®Google Scholar
• ManghamDCRowlandsDCNewboldKMReynoldsGMFieldingJWHallisseyMTExpression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic valueJ Clin Pathol19944754734747913101
   PubMedGoogle Scholar
• KakejiYMaeharaYAdachiYProliferative activity as a prognostic factor in Borrmann type 4 gastric carcinomaBr J Cancer19946947497537908217
   PubMedGoogle Scholar
• JainSFilipeMIHallPAWaseemNLaneDPLevisonDAPrognostic value of proliferating cell nuclear antigen in gastric carcinomaJ Clin Pathol19914486556591679766
   PubMedGoogle Scholar
• WangSCPCNA: a silent housekeeper or a potential therapeutic target?Trends Pharmacol Sci201435417818624655521
   PubMed Web of Science ®Google Scholar
• MalkasLHHerbertBSAbdel-AzizWA cancer-associated PCNA expressed in breast cancer has implications as a potential bio-markerProc Natl Acad Sci U S A200610351194721947717159154
   PubMedGoogle Scholar
• ZhaoHChenMSLoYHThe Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancerOncogene201433111429143723542172
   PubMed Web of Science ®Google Scholar
• ZhaoHLoYHMaLTargeting tyrosine phosphorylation of PCNA inhibits prostate cancer growthMol Cancer Ther2011101293621220489
   PubMed Web of Science ®Google Scholar
• YuYLChouRHLiangJHTargeting the EGFR/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptidesPLoS One201384e6136223593472
   PubMedGoogle Scholar
• TanZWortmanMDillehayKLSmall-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growthMol Pharmacol201281681181922399488
   PubMed Web of Science ®Google Scholar
• EggerMZellweger-ZahnerTSchneiderMJunkerCLengelerCAntesGLanguage bias in randomised controlled trials published in English and GermanLancet199735090743263299251637
   PubMed Web of Science ®Google Scholar